Description
The impact of chemotherapy on the host microbiota in the context of oral and gastrointestinal mucositis
- You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart
Article: The impact of chemotherapy on the host microbiota in the context of oral and gastrointestinal mucositis
€2.42
